Illicit Injectable Peptides and Regulatory Gaps

This Viewpoint discusses the growing presence of synthetic peptides in enhancement drug use and outlines regulatory gaps created by the blurring of boundaries between medicine and illicit use.

Corresponding Author: Timothy Piatkowski, PhD, The University of Queensland, Level 2, Public Health Building (887), 288 Herston Rd, Herston, QLD 4006, Australia (t.piatkowski@uq.edu.au).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.